Candida auris adhesins, specifically Als3, a key target to understand and mitigate

Als3 vaccine, antibodies, natural ligands, and others, although research in this area is still limited. Future research directions should include in-depth investigation of Als3 structural and molecular differences, in addition to the discovery of target drugs.